Form 4 Filing for Jamie L. Reynoso

2026-07-06SEC Filing 4 (0001839066-26-000031)

Jamie L. Reynoso, CEO, Medicare Advantage at CLOVER HEALTH INVESTMENTS, CORP. /DE, reported the sale of 6,229 shares of Class A Common Stock on July 6, 2026. The sale was conducted at a price of $5.26 per share, totaling $32,753.74. This transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units (RSUs). The RSUs were granted on January 3, 2023, and vest quarterly, with the final vesting date set for January 1, 2027. The sales are mandated by the company's equity incentive plan, requiring a "sell to cover" transaction to satisfy tax withholding, and do not represent discretionary trading by the reporting person. Following this transaction, Mr. Reynoso owns 2,834,982 shares of Class A Common Stock.